BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11498774)

  • 1. Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: effects on the invasive phenotype.
    Krueger S; Kellner U; Buehling F; Roessner A
    Cancer Gene Ther; 2001 Jul; 8(7):522-8. PubMed ID: 11498774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line.
    Krueger S; Haeckel C; Buehling F; Roessner A
    Cancer Res; 1999 Dec; 59(23):6010-4. PubMed ID: 10606250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense inhibition of urokinase: effect on malignancy in a human osteosarcoma cell line.
    Haeckel C; Krueger S; Roessner A
    Int J Cancer; 1998 Jul; 77(1):153-60. PubMed ID: 9639407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer cells express cathepsins B and L but not cathepsins K or H.
    Ishibashi O; Mori Y; Kurokawa T; Kumegawa M
    Cancer Biochem Biophys; 1999 Jul; 17(1-2):69-78. PubMed ID: 10738903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrigel invasion by the prostate cancer cell lines, PC3 and DU145, and cathepsin L+B activity.
    Colella R; Jackson T; Goodwyn E
    Biotech Histochem; 2004; 79(3-4):121-7. PubMed ID: 15621884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsins and osteosarcoma: Expression analysis identifies cathepsin K as an indicator of metastasis.
    Husmann K; Muff R; Bolander ME; Sarkar G; Born W; Fuchs B
    Mol Carcinog; 2008 Jan; 47(1):66-73. PubMed ID: 17683065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells.
    Colella R; Casey SF
    Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines.
    Zajc I; Sever N; Bervar A; Lah TT
    Cancer Lett; 2002 Dec; 187(1-2):185-90. PubMed ID: 12359367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrigel influences morphology and cathepsin B distribution of prostate cancer PC3 cells.
    Gopal P; Rehman RU; Chadha KS; Qiu M; Colella R
    Oncol Rep; 2006 Aug; 16(2):313-20. PubMed ID: 16820909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion.
    Cuvier C; Jang A; Hill RP
    Clin Exp Metastasis; 1997 Jan; 15(1):19-25. PubMed ID: 9009102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cathepsins B and L in human lung epithelial cells is regulated by cytokines.
    Gerber A; Welte T; Ansorge S; Bühling F
    Adv Exp Med Biol; 2000; 477():287-92. PubMed ID: 10849756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and transforming growth factor-beta 1 control expression of cathepsins B and L in human lung epithelial cells.
    Gerber A; Wille A; Welte T; Ansorge S; Bühling F
    J Interferon Cytokine Res; 2001 Jan; 21(1):11-9. PubMed ID: 11177576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis.
    Levicar N; Dewey RA; Daley E; Bates TE; Davies D; Kos J; Pilkington GJ; Lah TT
    Cancer Gene Ther; 2003 Feb; 10(2):141-51. PubMed ID: 12536203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antisense inhibition of urokinase in a human osteosarcoma cell line].
    Haeckel C; Krueger S; Roessner A
    Verh Dtsch Ges Pathol; 1998; 82():170-7. PubMed ID: 10095429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intracellular form of cathepsin B contributes to invasiveness in cancer.
    Szpaderska AM; Frankfater A
    Cancer Res; 2001 Apr; 61(8):3493-500. PubMed ID: 11309313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells.
    Kirschke H; Eerola R; Hopsu-Havu VK; Brömme D; Vuorio E
    Eur J Cancer; 2000 Apr; 36(6):787-95. PubMed ID: 10762753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64.
    Navab R; Mort JS; Brodt P
    Clin Exp Metastasis; 1997 Mar; 15(2):121-9. PubMed ID: 9062388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells.
    Kido A; Krueger S; Haeckel C; Roessner A
    Clin Exp Metastasis; 2003; 20(7):585-92. PubMed ID: 14669789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of cathepsin L in metastatic bone tumors.
    Park IC; Lee SY; Jeon DG; Lee JS; Hwang CS; Hwang BG; Lee SH; Hong WS; Hong SI
    J Korean Med Sci; 1996 Apr; 11(2):144-8. PubMed ID: 8835762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cell density decreases cysteine proteinase inhibitor activity and increases invasive ability of two prostate tumor cell lines.
    Colella R; Goodwyn E; Gopal P
    Cancer Lett; 2002 Nov; 185(2):163-72. PubMed ID: 12169390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.